Finney, he said that I should use a topical or oral finasteride to block DHT, the root cause of damage to my hair follicles, and strongly consider finishing a PRP series
BPC-157 TB-500 Side Effects & Safety BPC-157 Generally very well tolerated in research models Minimal reported side effects at standard doses No significant hormonal impact Theoretical concern: may promote angiogenesis in existing tumors (same as any pro-angiogenic compound) TB-500 Well tolerated
Temperature Control Unopened, dry vials of tirzepatide can often be stored at room temperature, but once bacteriostatic water is added, the vial must be refrigerated
In September 2023 the FDA placed BPC-157 in Category 2 of its 503A interim bulk-substances policy, citing immunogenicity and peptide-characterization concerns, effectively excluding it from the 503A compounding bulk-substances list
2025 (Online ahead of print)